Temple Therapeutics is a pharmaceutical clinical development company with a global footprint. We focus on diseases where abnormal tissue growth and dysfunction are common hallmarks and lead to fibrosis, pain, infertility and cancers. Surprisingly, there are either no, limited or completing ineffective therapies or diagnostics, yet it impacts hundreds of millions of people worldwide. BIOSURGERY – POST-SURGICAL TISSUE FIBROSIS/ADHESION PREVENTION -First local therapeutic (surgiceutical) entering phase 3 development -Category leader, no competitors in late stage clinical development ENDOMETRIOSIS -First non-invasive blood test to diagnose endometriosis -Novel non-hormonal therapeutic developed -ZERO programs in clinical development ONCOLOGY -Novel targeted therapy for recurrent, sensitive, & platinum resistant ovarian cancer in development -LIMITED therapies & poor outcomes for women